Approval · Notice of Compliance 4809 · 1995
FOSAMAX: Notice of Compliance 4809
Issued December 18, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4809
- Date
- December 18, 1995
- Company
- Merck Frosst Canada Inc.Kirkland, QC, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Bone metabolism regulator
Products in this notice
Medicinal ingredients
- ALENDRONATE SODIUM 10 MG per TAB
- ALENDRONATE SODIUM 40 MG per TAB